A 2024 coffee recall is in effect for products made by Snapchill due to concerns of botulism from the U.S. Food and Drug Administration (FDA).
Botulism is a type of food poisoning that can cause several negative side effects. They include weakness, dizziness, double vision, abdominal distension, distress and more. If not treated, it can be fatal.
Coffee Recall 2024: Products Affected
The 2024 coffee recall is due in part to the low-acid production method used by Snapchill. This can leave room for botulism to grow inside of the company’s canned coffee products.
According to New York Post, Snapchill opted to voluntarily recall some 250 products that it “distributed across the country to various roasters and vendors, as well as sold to consumers online.”
Those concerned about the recall can find a list of potentially affected coffee brands here.
There’s more news than just a 2024 coffee recall worth reading about today!
We have all of the hottest market news ready to go on Monday! A few examples include what’s happening with shares of Alnylam (NASDAQ:ALNY), Ginkgo Bioworks (NYSE:DNA) and G1 Therapeutics (NASDAQ:GTHX) stock today. All of this news is ready below!
More Stock Market News for Monday
- Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success
- Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts
- Why Is G1 Therapeutics (GTHX) Stock Down 56% Today?
On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
